Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 11BIAC2902

Acrylamide-bis-acryl, 40% (w/v), 29:1 Solution, MP Biomedicals™

Catalog No. 11BIAC2902 Shop All MP Biomedicals, Inc Products
Change view
Click to view available options
Quantity:
1 L
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
11BIAC2902 1 L
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 11BIAC2902 Supplier MP Biomedicals, Inc Supplier No. 11BIAC2902
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Description

Acrylamide-bis-acryl, 40% (w/v), 29:1 Solution is sequencing gel that provides convenient ready-to-use solutions of 4X high quality acrylamide for molecular biology.

  • Acrylamide/bis-acrylamide (40% w/v) 29:1 Solution is convenient ready-to-use solutions of 4X crystalized high quality acrylamide for molecular biology, and NN'-Methylenebisacrylamide in deionised water.
  • Premixed 19:1 liquid solution eliminates the need to weigh toxic acrylamide and bis-acrylamide.
  • The concentration is based on the total weight of both the acrylamide and bis-acrylamide.
  • Acrylamide/bis-acrylamide (40% w/v) 29:1 Solution is prepared from highly purified acrylamide (4X) and bis-acrylamide (2X) using deionized ultrafiltered water.
TRUSTED_SUSTAINABILITY

Specifications

Absorbance A290 (1% in water): ≤0.1
Physical Form Liquid
Composition Acrylamide/Bis-acrylamide 29:1
Quantity 1 L
Grade Molecular Biology

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov

Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.